tanshinone ii a has been researched along with lobaric acid in 1 studies
| Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) | Studies (lobaric acid) | Trials (lobaric acid) | Recent Studies (post-2010) (lobaric acid) |
|---|---|---|---|---|---|
| 61 | 0 | 41 | 34 | 0 | 20 |
| Protein | Taxonomy | tanshinone ii a (IC50) | lobaric acid (IC50) |
|---|---|---|---|
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 32.19 | |
| Ubiquitin-like modifier activating enzyme 2 | Homo sapiens (human) | 10.895 | |
| SUMO1 activating enzyme subunit 1 | Homo sapiens (human) | 10.895 | |
| envelope glycoprotein | Human immunodeficiency virus 1 | 13.1 | |
| SUMO-conjugating enzyme UBC9 | Homo sapiens (human) | 10.895 | |
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | 10.9648 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 0.835 | |
| G-protein coupled receptor 35 | Homo sapiens (human) | 4.54 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.6218 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.7244 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
1 other study(ies) available for tanshinone ii a and lobaric acid
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |